Publications by authors named "Erik Kemper"

AI tools in radiology are revolutionising the diagnosis, evaluation, and management of patients. However, there is a major gap between the large number of developed AI tools and those translated into daily clinical practice, which can be primarily attributed to limited usefulness and trust in current AI tools. Instead of technically driven development, little effort has been put into value-based development to ensure AI tools will have a clinically relevant impact on patient care.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the feasibility of safely drilling into the temporal bone for cochlear implant fixation, addressing the risk of complications like hematoma and cerebrospinal fluid leakage, especially in patients with thinner bones.
  • An innovative semi-automatic algorithm was developed to analyze 3D skull models, identifying the thickest areas of temporal bone and determining residual bone thickness after simulated drilling, with initial validation showing high accuracy in five test cases.
  • The algorithm offers a reliable method for assessing surgical feasibility and risks in patients with thinner temporal bones, potentially improving the safety and efficiency of cochlear implant surgeries.
View Article and Find Full Text PDF

Objectives: Previous research has demonstrated that patients with rheumatoid arthritis (RA) are less likely to breast feed their offspring. Treatment options for RA during lactation have expanded and the importance of counselling is recognised. The aim of the current research was to study breast feeding among women with RA who benefit from these developments.

View Article and Find Full Text PDF
Article Synopsis
  • The European League Against Rheumatism (EULAR) established points to minimize the transfer of tumor necrosis factor inhibitors (TNFi) to the placenta during pregnancy, which were validated by analyzing TNFi concentrations in cord blood.
  • In a study involving 111 patients, TNFi was stopped according to EULAR recommendations, with key stop times ranging from 18.4 to 37 weeks of gestation for different medications.
  • Results showed that certolizumab pegol, adalimumab, and infliximab had detectable levels in some cord blood samples, but compliance with EULAR guidelines generally led to low or absent TNFi levels in the newborns' blood.
View Article and Find Full Text PDF

Design thinking is an innovative, human-centered approach to problem-solving. In design thinking, teams step away from immediate and reactionary approaches to complex problems in favor of novel, broader approaches. The key tenets of empathy and user-centered insights are emphasized.

View Article and Find Full Text PDF